. Author manuscript; available in PMC: 2014 Sep 19.

Published in final edited form as: Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006654. doi: 10.1002/14651858.CD006654.pub2

Analysis 3.29. Comparison 3 OLANZAPINE versus CLOZAPINE, Outcome 29 Adverse effects: 8b. Metabolic - cholesterol - change from baseline in mg/dl.

Review: Olanzapine versus other atypical antipsychotics for schizophrenia

Comparison: 3 OLANZAPINE versus CLOZAPINE

Outcome: 29 Adverse effects: 8b. Metabolic - cholesterol - change from baseline in mg/dl